Using augmented reality in endoscopic skull base surgery

Application of Augmented Reality Neuronavigation in Transnasal Endoscopic Skull Base Surgery

This study tests whether using augmented reality during skull base surgery can help surgeons see better and reduce complications for patients with pituitary tumors and other related conditions.

Quick facts

• Phase: NA
• Study type: Interventional
• Enrollment: 10 (estimated)
• Sex: All
• Sponsor: The First Affiliated Hospital of Xiamen University (other)
• Locations: 1 site (Xiamen, Fujian)
• Trial ID: NCT06282224 on ClinicalTrials.gov

What this trial studies

This study explores the application of augmented reality (AR) technology in transnasal endoscopic surgery for pituitary neoplasms and other skull base lesions. The AR system enhances the surgeon's ability to visualize anatomical structures by creating a 3D reconstruction from preoperative imaging data, such as CT and MRI scans. It integrates real-time tracking of these structures during surgery, allowing for improved precision and safety. The intervention involves performing the surgery with an AR-integrated endoscope to potentially reduce complications associated with traditional methods.

Who should consider this trial

Good fit: Ideal candidates include patients suitable for transnasal endoscopic surgery who have undergone thin-layer head MRI and CTA scans.

Not a fit: Patients without clear preoperative imaging data or those who do not consent to the use of AR technology may not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could significantly improve surgical outcomes and reduce complications for patients undergoing skull base surgery.

How similar studies have performed: Other studies have shown promise in using augmented reality for surgical applications, indicating potential success for this novel approach.

Eligibility criteria

Inclusion Criteria：

* Patients who are suitable for Transnasal endoscopic surgery 。
* Patients who have performed thin-layer head MRI and CTA scans before surgery.

Exclusion Criteria：

* Patients without clear preoperative imaging data.
* Patients who do not agree to receive the assistance of AR fusion neuroendoscopy.
* Patients with incomplete medical records.

Where this trial is running

Xiamen, Fujian

• The First Affiliated Hospital of Xiamen University — Xiamen, Fujian, China (RECRUITING)

Study contacts

• Study coordinator: Hongwei Zhu, doctorate

Conditions: Pituitary Neoplasms, augmented reality, Transnasal endoscopic surgery, applied research, basicranial tumor